Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressants.

Marian Fireman1, Andrea F DiMartini, Scott C Armstrong

  • 1Department of Psychiatry, Oregon Health and Science University, Portland, OR 97239-3098, USA. firemanm@ohsu.edu

Psychosomatics
|July 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of a positive phosphatidylethanol test from blood transfusion and implications for access to clinical care.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Obtaining and Documenting Informed Consent: An Advanced UME Cross-Specialty, Role-Playing Skill Builder.

MedEdPORTAL : the journal of teaching and learning resources·2026
Same author

Building Faculty Performance Evaluation from the Ground-Up: Designing Tools and Gauging Acceptance.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2025
Same author

Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement.

Nature reviews. Gastroenterology & hepatology·2024
Same author

Gut and bladder fermentation syndromes: a narrative review.

BMC medicine·2024
Same author

Definition and measurement of alcohol-associated insight in early liver transplantation for acute alcohol-associated hepatitis: A systematic review.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2023
Same journal

Clinical Approach to Personality Change Due to Another Medical Condition.

Psychosomatics·2021
Same journal

Clonazepam for Catatonia Incompletely Responsive to lorazepam.

Psychosomatics·2021
Same journal

Diabetic Retinopathy and Depression: A Risk Assessment.

Psychosomatics·2021
Same journal

WITHDRAWN: Psychosis: A Presentation of COVID-19?

Psychosomatics·2021
Same journal

Dermatitis Neglecta, the Cognitive Assessment, and Micronutrients.

Psychosomatics·2020
Same journal

Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Psychosomatics·2020
See all related articles

Managing patients on immunosuppressants for transplants or autoimmune disorders is complex due to side effects and drug interactions. Understanding pharmacokinetics is crucial to prevent toxicity or treatment failure.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Transplantation Medicine

Background:

  • Immunosuppressants are vital for preventing organ transplant rejection and treating autoimmune diseases.
  • Consultation-liaison psychiatry frequently manages patients on these medications, facing increasing patient numbers and expanded indications.
  • These patients often have comorbid conditions requiring additional pharmacologic treatments.

Purpose of the Study:

  • To review the pharmacokinetic drug-drug interaction profiles of commonly used immunosuppressants.
  • To highlight the challenges in managing patients on multiple medications, including immunosuppressants and treatments for comorbid illnesses.
  • To emphasize the importance of understanding drug interactions to prevent adverse events and maintain therapeutic efficacy.

Main Methods:

Related Experiment Videos

  • Review of pharmacokinetic properties of key immunosuppressant drugs.
  • Analysis of potential drug-drug interactions between immunosuppressants and other medications.
  • Discussion of clinical implications of altered serum drug levels.

Main Results:

  • Immunosuppressants can cause significant physical, mental, and biochemical side effects.
  • Drug-drug interactions can lead to increased immunosuppressant levels (toxicity) or decreased levels (treatment failure).
  • Altered serum levels of comorbid medications can also occur, leading to adverse events.

Conclusions:

  • Knowledge of pharmacokinetic interactions is essential for safe and effective management of patients on immunosuppressants.
  • Careful medication management is required to avoid toxicity and maintain therapeutic outcomes in transplant recipients and autoimmune disorder patients.
  • This review details interactions for glucocorticoids, cyclosporine, tacrolimus, sirolimus, mycophenolate mofetil, azathioprine, and monoclonal antibodies.